From the Department of Anesthesiology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas (S.D.G., M.L.J., N.V., S.J.G., C.Y.W., H.K.E.) the Department of Anesthesiology, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany (F.K.).
Anesthesiology. 2020 Jan;132(1):180-204. doi: 10.1097/ALN.0000000000002968.
Perioperative organ injury is among the leading causes of morbidity and mortality of surgical patients. Among different types of perioperative organ injury, acute kidney injury occurs particularly frequently and has an exceptionally detrimental effect on surgical outcomes. Currently, acute kidney injury is most commonly diagnosed by assessing increases in serum creatinine concentration or decreased urine output. Recently, novel biomarkers have become a focus of translational research for improving timely detection and prognosis for acute kidney injury. However, specificity and timing of biomarker release continue to present challenges to their integration into existing diagnostic regimens. Despite many clinical trials using various pharmacologic or nonpharmacologic interventions, reliable means to prevent or reverse acute kidney injury are still lacking. Nevertheless, several recent randomized multicenter trials provide new insights into renal replacement strategies, composition of intravenous fluid replacement, goal-directed fluid therapy, or remote ischemic preconditioning in their impact on perioperative acute kidney injury. This review provides an update on the latest progress toward the understanding of disease mechanism, diagnosis, and managing perioperative acute kidney injury, as well as highlights areas of ongoing research efforts for preventing and treating acute kidney injury in surgical patients.
围手术期器官损伤是外科患者发病率和死亡率的主要原因之一。在不同类型的围手术期器官损伤中,急性肾损伤尤其常见,对手术结果有极大的不利影响。目前,急性肾损伤最常通过评估血清肌酐浓度升高或尿量减少来诊断。最近,新型生物标志物已成为改善急性肾损伤的及时检测和预后的转化研究的重点。然而,生物标志物释放的特异性和时间仍然对将其纳入现有诊断方案构成挑战。尽管许多临床试验使用了各种药物或非药物干预措施,但仍缺乏可靠的方法来预防或逆转急性肾损伤。尽管如此,最近的几项随机多中心试验为肾替代策略、静脉输液替代物的组成、目标导向液体治疗或远程缺血预处理在围手术期急性肾损伤中的影响提供了新的见解。本文综述了在理解围手术期急性肾损伤的发病机制、诊断和治疗方面的最新进展,并强调了当前在预防和治疗外科患者急性肾损伤方面的研究工作重点。